KANK1
protein-codingKN motif and ankyrin repeat domains 1, the group of KN motif and ankyrin repeat domain containing
Gene summary
The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
- ANKRD15
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~275.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013033
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013033
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0005377
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0016215
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013033
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0013033
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KANK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015158.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 223 | 230 | |||
| missense | 1 | 569 | 118 | 2 | 690 | |
| nonsense | 17 | 17 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 20 | 1 | 21 | |||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 0 | 1 | 627 | 341 | 3 | 972 |
Highest pathogenic variant AF is 0.0000027366818
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055973.2 | 11 | MANE Select | |
| Ensembl | ENSP00000371734.2 | 11 | MANE Select | |
| RefSeq | NP_001243805.1 | 11 | Standard | |
| RefSeq | NP_001243806.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- cell population proliferation
- negative regulation of neuron projection development
- actin cytoskeleton organization
- positive regulation of Wnt signaling pathway
- negative regulation of cell migration
Molecular Function
- protein binding
- beta-catenin binding
Cellular Component
- nucleus
- cytoplasm
- plasma membrane
- ruffle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382303
- Coding exons
- 11
- Length
- 275815
- Individuals with no LoFs
- 125621
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 127
- Defined
- 125748
- p
- 0.000505
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -4.81 | 1165 | 786 | 1.48 | 0.0000446 | 8877 |
| Missense (PolyPhen) | 343 | 247.94 | 1.3834 | 2814 | ||
| Synonymous | -5.27 | 433 | 314 | 1.38 | 0.0000193 | 2711 |
| Loss of Function | 1.84 | 34 | 47.7 | 0.712 | 0.00000245 | 581 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00078 | 0.00078 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0010 | 0.0010 | notable |
| Finnish | 0.00065 | 0.00065 | rare |
| European (Non-Finnish) | 0.00044 | 0.00043 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the control of cytoskeleton formation by regulating actin polymerization. Inhibits actin fiber formation and cell migration. Inhibits RhoA activity; the function involves phosphorylation through PI3K/Akt signaling and may depend on the competetive interaction with 14-3-3 adapter proteins to sequester them from active complexes. Inhibits the formation of lamellipodia but not of filopodia; the function may depend on the competetive interaction with BAIAP2 to block its association with activated RAC1. Inhibits fibronectin-mediated cell spreading; the function is partially mediated by BAIAP2. Inhibits neurite outgrowth. Involved in the establishment and persistence of cell polarity during directed cell movement in wound healing. In the nucleus, is involved in beta-catenin-dependent activation of transcription. Potential tumor suppressor for renal cell carcinoma. {ECO:0000269|PubMed:16968744, ECO:0000269|PubMed:18458160, ECO:0000269|PubMed:19171758, ECO:0000269|PubMed:22084092}.;
Recessive Scores
- pRec
- 0.0989
Intolerance Scores
- LoFtool
- 0.810
- RVIS EVS
- -0.92
- RVIS percentile EVS
- 9.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.205
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |